Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Mikus

Showing results (81-90 of 86) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 86 results.
Arzneimittel-Forschung|February 5, 1998
Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. 2nd communication: investigations on theophylline-like activitiesE G Mikus, Z Kapui, D Korbonits, et al.
British Journal of Clinical Pharmacology|April 5, 2018
Higher chlorzoxazone clearance in obese children compared with nonobese peersC Gade, K Dalhoff, T S Petersen, et al.
European Journal of Pharmacology|December 11, 2012
Interaction of SSR161421, a novel specific adenosine A(3) receptor antagonist with adenosine A(3) receptor agonists both in vitro and in vivoEndre G Mikus, Kinga Boér, Géza Timári, et al.
Plos One|July 24, 2020
Preclinical characterization of CPL302-253, a selective inhibitor of PI3Kδ, as the candidate for the inhalatory treatment and prevention of AsthmaPaweł Gunerka, Kamila Gala, Martyna Banach, et al.
European Journal of Pain (London, England)|December 20, 2016
European Pain Federation position paper on appropriate opioid use in chronic pain managementT O'Brien, L L Christrup, A M Drewes, et al.
Clinical Pharmacology and Therapeutics|May 26, 2017
The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir PharmacokineticsA Blank, A Eidam, M Haag, et al.
Pageof 9

Showing results (81-90 of 86) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 86 results.
Arzneimittel-Forschung|February 5, 1998
Experimental studies on the antitussive properties of the new xanthine derivative 1H-purine-2,6-dione, 3,7-dihydro-3-methyl-7[(5-methyl-1,2,4-oxadiazol-3-yl)methyl]. 2nd communication: investigations on theophylline-like activitiesE G Mikus, Z Kapui, D Korbonits, et al.
British Journal of Clinical Pharmacology|April 5, 2018
Higher chlorzoxazone clearance in obese children compared with nonobese peersC Gade, K Dalhoff, T S Petersen, et al.
European Journal of Pharmacology|December 11, 2012
Interaction of SSR161421, a novel specific adenosine A(3) receptor antagonist with adenosine A(3) receptor agonists both in vitro and in vivoEndre G Mikus, Kinga Boér, Géza Timári, et al.
Plos One|July 24, 2020
Preclinical characterization of CPL302-253, a selective inhibitor of PI3Kδ, as the candidate for the inhalatory treatment and prevention of AsthmaPaweł Gunerka, Kamila Gala, Martyna Banach, et al.
European Journal of Pain (London, England)|December 20, 2016
European Pain Federation position paper on appropriate opioid use in chronic pain managementT O'Brien, L L Christrup, A M Drewes, et al.
Clinical Pharmacology and Therapeutics|May 26, 2017
The NTCP-inhibitor Myrcludex B: Effects on Bile Acid Disposition and Tenofovir PharmacokineticsA Blank, A Eidam, M Haag, et al.
Pageof 9